Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada)

BACKGROUND: In patients chronically infected with the hepatitis C virus (HCV), it is not established whether viral outcomes or health-related quality of life (HRQoL) differ between individuals treated at academic or community centres.

Bibliographic Details
Main Authors:	Robert P Myers, Curtis Cooper, Morris Sherman, Richard Lalonde, Helga Witt-Sullivan, Magdy Elkashab, Paul Harris, Rob Balshaw, Christopher Usaty, Paul J Marotta
Format:	Article
Language:	English
Published:	Hindawi Limited 2011-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/2011/698780

id	doaj-11fae779ae104a3f83f0e2227a7a4673
record_format	Article
spelling	doaj-11fae779ae104a3f83f0e2227a7a46732020-11-24T23:24:45ZengHindawi LimitedCanadian Journal of Gastroenterology0835-79002011-01-0125950351010.1155/2011/698780Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada)Robert P Myers0Curtis Cooper1Morris Sherman2Richard Lalonde3Helga Witt-Sullivan4Magdy Elkashab5Paul Harris6Rob Balshaw7Christopher Usaty8Paul J Marotta9Liver Unit, University of Calgary, Calgary, Alberta, CanadaUniversity of Ottawa, Ottawa, CanadaUniversity Health Network, Toronto, Ontario, CanadaMcGill University, Montreal, Quebec, CanadaMcMaster University, Hamilton, CanadaToronto Liver Centre, Toronto, Ontario, CanadaUniversity of Saskatchewan, Saskatoon, Saskatchewan, CanadaSyreon Corporation, Vancouver, British Columbia, CanadaHoffmann-La Roche Ltd, Mississauga, CanadaUniversity of Western Ontario, London, Ontario, CanadaBACKGROUND: In patients chronically infected with the hepatitis C virus (HCV), it is not established whether viral outcomes or health-related quality of life (HRQoL) differ between individuals treated at academic or community centres.http://dx.doi.org/10.1155/2011/698780
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Robert P Myers Curtis Cooper Morris Sherman Richard Lalonde Helga Witt-Sullivan Magdy Elkashab Paul Harris Rob Balshaw Christopher Usaty Paul J Marotta
spellingShingle	Robert P Myers Curtis Cooper Morris Sherman Richard Lalonde Helga Witt-Sullivan Magdy Elkashab Paul Harris Rob Balshaw Christopher Usaty Paul J Marotta Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada) Canadian Journal of Gastroenterology
author_facet	Robert P Myers Curtis Cooper Morris Sherman Richard Lalonde Helga Witt-Sullivan Magdy Elkashab Paul Harris Rob Balshaw Christopher Usaty Paul J Marotta
author_sort	Robert P Myers
title	Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada)
title_short	Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada)
title_full	Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada)
title_fullStr	Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada)
title_full_unstemmed	Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada)
title_sort	outcomes of chronic hepatitis c therapy in patients treated in community versus academic centres in canada: final results of approach (a prospective study of peginterferon alfa-2a and ribavirin at academic and community centres in canada)
publisher	Hindawi Limited
series	Canadian Journal of Gastroenterology
issn	0835-7900
publishDate	2011-01-01
description	BACKGROUND: In patients chronically infected with the hepatitis C virus (HCV), it is not established whether viral outcomes or health-related quality of life (HRQoL) differ between individuals treated at academic or community centres.
url	http://dx.doi.org/10.1155/2011/698780
work_keys_str_mv	AT robertpmyers outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada AT curtiscooper outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada AT morrissherman outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada AT richardlalonde outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada AT helgawittsullivan outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada AT magdyelkashab outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada AT paulharris outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada AT robbalshaw outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada AT christopherusaty outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada AT pauljmarotta outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada
_version_	1725558977207468032

Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada)

Similar Items